Taylor Wessing Scoops MIP Award

Taylor Wessing scoops MIP award for European Life Sciences IP Firm of the Year

Taylor Wessing was voted European Life Sciences IP Firm of the Year at the third annual Managing Intellectual Property Global Awards ceremony at Claridges Hotel, London, on 9 April.

The Global Awards are awarded to single firms, corporations and individuals excelling across the board for their IP expertise, and mark the culmination of a five month-long World IP Survey research undertaken by MIP.

This award comes on the back of a hugely successful year for Taylor Wessing's Life Sciences and Healthcare Group, during which it advised on many high-profile cases and transactions. Among them was advising Oxford BioMedica on its exclusive worldwide licence to Sanofi-Aventis of the cancer vaccine Trovax. This deal was duly recognised by being awarded SCRIP's "Licensing Deal of the Year Award" and the "techMARK 2007 Achievement of the Year Award" in the techMARK Awards organised by the London Stock Exchange.

On the patent litigation side, Taylor Wessing acted for Cargill in the first genetically modified crops trial in the UK. It successfully defended an action brought on three patents by Monsanto for importation from Argentina of allegedly infringing soya meal into the UK derived from glyphosate-resistant soya bean plants.

Daniel Pavin, Partner in the Life Sciences and Healthcare Group at Taylor Wessing, comments:

"We are delighted with this award, which recognises the market leading strength and breadth of expertise Taylor Wessing can provide to the life sciences sector."